Skip to content

Cognitive and Emotional Factors in Visual Exploration Among Patients With Post-Traumatic Stress Disorder (SAILLANCE2)

Cognitive and Emotional Factors in Visual Exploration Among Patients With Post-Traumatic Stress Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03519789
Acronym
SAILLANCE2
Enrollment
80
Registered
2018-05-09
Start date
2014-05-01
Completion date
2020-05-05
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Stress Disorder

Keywords

Change blindness, Eye tracking, Implicit response

Brief summary

Post-traumatic stress disorder (PTSD) is characterized by hypervigilance. In particular, previous works suggest that patients tend to scan constantly the environment for possible threats. The present project aims at investigating such attentional bias in patients with PTSD using the change blindness paradigm that offers the interesting possibility of studying sensitivity to sudden changes using ecological stimuli. More precisely, the investigators will investigate whether patients are more sensitive than matched controls to sudden changes in the visual environment and whether this hypersensitivity is specific or even stronger when visual information has an emotional content. The attentional bias will be measured using motor responses (accuracy and speed to indicate the occurrence of a change by pressing a button) as well as eye movements.

Interventions

None listed

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* a diagnosis of PTSD based on the standard DSM-IV criteria, * normal or corrected vision. * clinically stable at the testing time

Exclusion criteria

* history of neurological illness or trauma that occurred in the previous six months, - pregnant and nursing women, * drugs use in the last 24 hours, * an acute ocular disorder. * Participants will not be under tutorship, curatorship or deprived of liberty.

Design outcomes

Primary

MeasureTime frameDescription
Response time before the detection of neutral and emotional stimuli.Baseline: one sessionThe explicit response of the participants will be measured with the response time before the detection of neutral and emotional stimuli.

Secondary

MeasureTime frameDescription
Number of correct detections compared with the missed detections and false alarms.Baseline: one sessionPerformances will be measured by a sensitivity index (D prime) . This sensitivity index considers the number of correct detections compared with the missed detections and false alarms.
Total duration until the participant first fixed on a ROI.Baseline: one sessionThe implicit response will be measured by the localization and duration of fixations. All fixations outside the recording field will be excluded. The main variable will be the mean latency of the first fixation in a region of interest (ROI). This variable corresponds to the total duration until the participant first fixed on a ROI.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORGuillaume VAIVA

University Hospital, Lille

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026